Samsung Biologics union authorizes strike action

Workers at Samsung Biologics have overwhelmingly voted to authorize strike action, signaling a potential first-ever work stoppage for the company. This decision comes amid a deadlock in ongoing pay negotiations between the union and management. The union's authorization empowers its leaders to call for a strike if a resolution cannot be reached, raising concerns about potential disruptions to the biopharmaceutical giant's operations. The outcome of these talks will be closely watched by industry observers and employees alike.